The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives

被引：19
作者：
Walsh, Robert J. [1 ]
Tan, David S. P. [1 ,2 ]
机构：
[1] Natl Univ Canc Inst, Singapore 119074, Singapore
[2] Natl Univ Singapore, Canc Sci Inst, Singapore 117599, Singapore
来源：
JOURNAL OF CLINICAL MEDICINE | 2021年 / 10卷 / 19期
基金：
英国医学研究理事会;
关键词：
cervical cancer; immunotherapy; immune checkpoint inhibitor; SQUAMOUS-CELL CARCINOMA; NIVOLUMAB PLUS IPILIMUMAB; PHASE-II; T-CELLS; MICROSATELLITE INSTABILITY; INTRAEPITHELIAL NEOPLASIA; ACQUIRED-RESISTANCE; EXPRESSION; CHEMOTHERAPY; PD-L1;
D O I：
10.3390/jcm10194523
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cervical cancer remains one of the most common cancers in women around the world however therapeutic options in the advanced and recurrent setting are limited. Immune checkpoint inhibitors (ICI) have been considered an attractive option given the viral etiology of cervical cancer although the majority of patients do not benefit from their use. This review summarises current knowledge and use of immune checkpoint blockade in cervical cancer as well as discussing the challenges faced in their clinical application, namely, the role of biomarker-driven ICI use, potential mechanisms of resistance, strategies to overcome such resistance and additional immunotherapy options beyond ICI.
引用
收藏
页数：14
相关论文
共 89 条
  • [31] Efficacy of PD-1 blockade in cervical cancer is related to a CD8+FoxP3+CD25+ T-cell subset with operational effector functions despite high immune checkpoint levels
    Heeren, A. M.
    Rotman, J.
    Stam, A. G. M.
    Pocorni, N.
    Gassama, A. A.
    Samuels, S.
    Bleeker, M. C. G.
    Mom, C. H.
    Zijlmans, H. J. M. A. A.
    Kenter, G. G.
    Jordanova, E. S.
    de Gruijl, T. D.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [32] Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix
    Heeren, A. Marijne
    Punt, Simone
    Bleeker, Maaike C. G.
    Gaarenstroom, Katja N.
    van der Velden, Jacobus
    Kenter, Gemma G.
    de Gruijl, Tanja D.
    Jordanova, Ekaterina S.
    [J]. MODERN PATHOLOGY, 2016, 29 (07) : 753 - 763
  • [33] High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer
    Heeren, A. Marijne
    Koster, Bas D.
    Samuels, Sanne
    Ferns, Debbie M.
    Chondronasiou, Dafni
    Kenter, Gemma G.
    Jordanova, Ekaterina S.
    de Gruijl, Tanja D.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (01) : 48 - 58
  • [34] First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
    Horn, L.
    Mansfield, A. S.
    Szczesna, A.
    Havel, L.
    Krzakowski, M.
    Hochmair, M. J.
    Huemer, F.
    Losonczy, G.
    Johnson, M. L.
    Nishio, M.
    Reck, M.
    Mok, T.
    Lam, S.
    Shames, D. S.
    Liu, J.
    Ding, B.
    Lopez-Chavez, A.
    Kabbinavar, F.
    Lin, W.
    Sandler, A.
    Liu, S. V.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (23) : 2220 - 2229
  • [35] Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer
    Huang, Ruea-Yea
    Francois, Ariel
    McGray, A. J. Robert
    Miliotto, Anthony
    Odunsi, Kunle
    [J]. ONCOIMMUNOLOGY, 2017, 6 (01):
  • [36] ADXS11-001 immunotherapy in squamous or non-squamous persistent/recurrent metastatic cervical cancer: Results from stage I of the phase II GOG/NRG0265 study.
    Huh, Warner King
    Dizon, Don S.
    Powell, Matthew A.
    Leath, Charles A.
    Landrum, Lisa Michelle
    Tanner, Edward
    Higgins, Robert
    Ueda, Stefanie M.
    McHale, Michael T.
    Monk, Bradley J.
    Aghajanian, Carol
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [37] Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.
    Jazaeri, Amir A.
    Zsiros, Emese
    Amaria, Rodabe Navroze
    Artz, Andrew S.
    Edwards, Robert P.
    Wenham, Robert Michael
    Slomovitz, Brian M.
    Walther, Axel
    Thomas, Sajeve Samuel
    Chesney, Jason Alan
    Morris, Robert
    Matsuo, Koji
    Gaillard, Stephanie
    Rose, Peter Graham
    Garcia Donas, Jesus
    Tromp, Jacqueline Maria
    Tavakkoli, Fatemeh
    Li, Huiling
    Fardis, Maria
    Monk, Bradley J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [38] Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.21492, 10.3322/caac.20115, 10.3322/caac.20107]
  • [39] Comparative molecular profiling of HPV-induced squamous cell carcinomas
    Koncar, Robert F.
    Feldman, Rebecca
    Bahassi, El Mustapha
    Sadraei, Nooshin Hashemi
    [J]. CANCER MEDICINE, 2017, 6 (07): : 1673 - 1685
  • [40] Scientific Rationale for Combination Immunotherapy of Hepatocellular Carcinoma with Anti-PD-1/PD-L1 and Anti-CTLA-4 Antibodies
    Kudo, Masatoshi
    [J]. LIVER CANCER, 2019, 8 (06) : 413 - 426
123456789